1233354-60-3

Basic information

• Product Name: 7-methoxy-3-oxo-3,4-dihydro-1H-2-benzopyran-8-yl 3-fluorobenzene-1-sulfonate
• Synonyms: 7-methoxy-3-oxo-3,4-dihydro-1H-2-benzopyran-8-yl 3-fluorobenzene-1-sulfonate
• CAS NO: 1233354-60-3
• Molecular Weight: 352.34
• Mol File: 1233354-60-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 7-methoxy-3-oxo-3,4-dihydro-1H-2-benzopyran-8-yl 3-fluorobenzene-1-sulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 7-methoxy-3-oxo-3,4-dihydro-1H-2-benzopyran-8-yl 3-fluorobenzene-1-sulfonate(1233354-60-3)
• EPA Substance Registry System: 7-methoxy-3-oxo-3,4-dihydro-1H-2-benzopyran-8-yl 3-fluorobenzene-1-sulfonate(1233354-60-3)

Safety Data

• Hazardous Substances Data: 1233354-60-3(Hazardous Substances Data)

Upstream product

• 56201-87-7 8-hydroxy-7-methoxyisobenzofuranyltetrahydropyran-3-one 
• 701-27-9 3-fluorobenzene-1-sulfonyl chloride 
• 1131-94-8 homoisovanillic acid 
• 774-81-2 (3-bromo-4-methoxy-phenyl)-acetic acid 
• 104-01-8 4-Methoxyphenylacetic acid 

Downstream Products

• 1233354-62-5 2-(hydroxymethyl)-6-methoxy-3-({[2-(3-methoxyphenyl)ethyl]carbamoyl}methyl)phenyl-3-fluorobenzene-1-sulfonate 
• 1233354-63-6 C₂₆H₂₆FNO₈S 
• 1233354-89-6 C₂₅H₂₆FNO₆S 
• 1233354-61-4 C₂₆H₂₈FNO₈S 
• 1233354-70-5 C₂₇H₂₈FNO₉S 
• 1233353-87-1 3,10-dimethoxy-5,6,7,8,13,13a-hexahydroisoquinolino[2,1-b]isoquinolin-9-yl 3-fluorobenzenesulfonate 

Relevant articles and documents

Tetrahydropalmatine derivative and application thereof

The invention relates to a tetrahydropalmatine derivative and application thereof, a compound as shown in a formula (VI) and a preparation method thereof, and an application of the compound in medicine. Specifically, the invention relates to a derivative of the compound as shown in the general formula (VI) and a preparation method thereof, and an application of the derivative as a therapeutic agent in prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, diabetes type II, hyperglycemia, adiposis, or insulin resistance and metabolic syndrome. The compound disclosed by the invention also can reduce total cholesterol, low density lipoprotein (LDL)-cholesterol and triglycerides, and increases the expression of a liver LDL receptor and inhibits the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9).

Tetrahydrocoptisine derivative and applications thereof

The present invention relates to a compound as shown in a formula (VII), a preparation method and applications thereof in medicines. In particular, the present invention relates to a derivative of the compound as shown in the formula (VII), a preparation method, and the applications of the derivative used as a therapeutic agent in prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, II-type diabetes, hyperglycemia, obesity or insulin resistance syndrome and metabolic syndrome. The compound disclosed by the present invention can also reduce total cholesterol, LDL-cholesterol and triglyceride, and increases expression of a liver LDL receptor and decreases expression of PCSK9.